Neuromuscular Junction Acetylcholine Release Machinery (NMJ ACh Release Machinery)

The neuromuscular junction (NMJ) acetylcholine (ACh) release machinery refers to the molecular and cellular components responsible for the synthesis, storage, regulated exocytosis, and synaptic clearance of acetylcholine at the synapse between a motor neuron and a skeletal muscle fiber. This machinery is essential for translating neuronal action potentials into muscle contraction. Key components include the presynaptic terminal, synaptic vesicles, SNARE proteins, voltage-gated calcium channels, vesicular acetylcholine transporter (VAChT), and acetylcholinesterase (AChE). The mechanism involves action potential arrival, calcium influx, SNARE-mediated vesicle fusion, ACh release, receptor binding, and signal termination. Regulation occurs presynaptically through autoreceptors and neurotrophic factors. Disruption can result from toxins (e.g., botulinum toxin), autoimmune diseases, or genetic defects. Targeted pharmacologically by toxins and drugs affecting cholinergic transmission, and defects are implicated in disorders like congenital myasthenic syndromes or botulism.

Other names

Presynaptic Acetylcholine Release MachineryNMJ Presynaptic TerminalCholinergic Neurotransmission at NMJ

Regulates acetylcholine release at the neuromuscular junction, modulating muscle contraction.